Target intelligence / Profile preview

PABPC5 antisense RNA 1 (PABPC5-AS1)

Target
PABPC5-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

PABPC5 antisense RNA 1 (PABPC5-AS1) is a long non-coding RNA (lncRNA) transcribed from the strand opposite to the PABPC5 gene. It is also known as CXorf46 or OTTHUMG00000021960 and does not encode a protein[3]. As with many antisense lncRNAs, PABPC5-AS1 is presumed to regulate the expression of its paired sense gene, in this case, cytoplasmic poly(A)-binding protein 5 (PABPC5), likely by interacting with PABPC5 mRNA or influencing transcription, though detailed functional mechanisms and physiological pathways are not well-characterized in current curated resources[3][6]. There is no evidence it is directly considered a therapeutic target, nor are there drugs known to interact with it, and its role as a biomarker or safety concern is not established. Notes and Sourcing: - The available search results provide only core bioinformatic and general functional information regarding lncRNA antisense transcripts, their regulatory activities, and their roles in gene expression regulation[3][6]. - No specific disease links, drug interactions, or therapeutic targeting roles are reported for PABPC5-AS1 as of the literature indexed in the search. - Classification as "lncRNA" and "antisense RNA" is based on gene annotation and general antisense RNA function studies[3][6].

Other names
OTTHUMG00000021960CXorf46PABPC5 antisense RNA 1 (non-protein coding)PABPC5-AS1
02

Biological functions

Regulation of gene expressionAntisense RNA-mediated modulation of the sense gene (PABPC5)Potential regulation of mRNA stabilityOther
03

Disease associations

Other (No strong, direct evidence of involvement in major disease areas as of this search)

Beyond the preview

Go deeper on PABPC5 antisense RNA 1 (PABPC5-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PABPC5 antisense RNA 1 (PABPC5-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call